Trent Evan
Known title: SVP, Chief Strat. & TransformCIK: 0001937575
Associated companies
Transaction History
| CVSA | ▼ Sell | Tax Withholding | 355 | $34K | 11/13/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 1,673 | $162K | 11/12/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 296 | $40K | 8/25/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 605 | $82K | 8/24/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 3,701 | $499K | 8/24/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 8,352 | $1.1M | 8/24/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 4,113 | $555K | 8/23/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 582 | $79K | 8/23/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 9,312 | $1.3M | 8/23/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 2,400 | $216K | 11/13/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 312 | $24K | 8/26/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 351 | $26K | 8/25/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 296 | $22K | 8/25/2024 | View on chart |
| CVSA | ▲ Buy | Grant | 1,026 | $77K | 8/25/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 455 | $34K | 8/25/2024 | View on chart |
| CVSA | ▲ Buy | Grant | 792 | $60K | 8/25/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 606 | $46K | 8/24/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 570 | $43K | 8/23/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 169 | $7K | 8/29/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 206 | $9K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 345 | $15K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 323 | $14K | 8/26/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 1,134 | $49K | 8/26/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 1,213 | $52K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 190 | $8K | 8/25/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 396 | $17K | 8/24/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 3,940 | $169K | 8/23/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.